The size of the EU Hormone Replacement Therapeutics Market size is valued at USD 3.86 billion in 2019 and is predicted to become a USD XX billion market by 2028, growing at a CAGR of XX% during the forecast period 2019-2028

Hormone replacement is recommended for replenishing the hormones in the human body when the hormone levels in the body drop as compared to the standard levels required for the proper functioning of the body. Hormonal imbalance disorders, including menopause, are the key factors driving the market for hormone replacement therapy. The female body undergoes several types of hormonal changes. Hormone levels get altered with growing age, leading to various disorders and diseases. Certain challenges faced due to hormonal imbalance are weight gain, fatigue, memory decline, low libido, and muscle loss. Menopausal females are the leading population base influencing the market. The average starting age of menopause amongst women is around 45 to 50 years. In menopausal women, the hormonal levels of progesterone & estrogen decrease considerably



Market Growth Drivers

The key growth driver of the EU Hormone Replacement Therapeutics market is the increasing awareness about post-menopausal problems amongst women. The other growth driver are availability and development novel formulations, the presence of unmet medical needs that require the employment of hormone therapies. The risk of side effects, such as bleeding, bloating, mood changes, and nausea, breast tenderness or enlargement, headaches, risk of breast cancer, heart disease, and stroke is blocking the growth of the market